th Leukemia and Hematologic Oncology · conferenceseries.com Hematologic Oncology 2017 Conference Secretariat Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson,

http://leukemia.conferenceseries.com/

Hematologic Oncology 2017conferenceseries.com

Conference SecretariatConference Series LLC 2360 Corporate Circle, Suite 400 Henderson, NV 89074-7722, USA

Tel: +1-888-843-8169, Fax: +1-650-618-1417, Ph: +1-650-268-9744, Toll free: +1-800-216-6499Email: [email protected], [email protected]

Tentative Program


conferenceseries.com

Theme: “Inspiring Innovations and Interactive discussions on Leukemia and Hematologic Oncology care”

**For Available Speaker Slots**[email protected]

9th International Conference on

Leukemia and Hematologic Oncology October 05-06,2017 London,UK





Conference Highlights

• Leukemia

• Hemotology

• Hematologic-oncology

• Blood Disorders and Blood oncology

• Leukemia immunology

• Hemato Immunology &Stem Cell Research

• Cancer and Alternative Medicine

• Haematological malignancies

• Haematological malignancies: Prognosis

• Biomarkers

• Bone Marrow Transplantation and surgery

• Advance in Bone Marrow Transplantation

Note: Workshops and Symposia slots are available. To book slot for Workshop and Symposium send us the proposal.

Call for Abstract: http://leukemia.conferenceseries.com/call-for-abstracts.php

Registration: http://leukemia.conferenceseries.com/registration.php

Abstract Submission: http://leukemia.conferenceseries.com/abstract-submission.php

Poster Competition: http://leukemia.conferenceseries.com/poster-competition.php



Series of Hematologic Oncology Conferences



Glimpses of Hematologic Oncology Conferences



Plan your Trip to London

British Museum

London Eye At Night

St’s Paul’s Cathedral

London Natural History Museum

Buckingham Palace

Palace Of Westminster

Tower Of London

London Bridge

October 17-18, 2016 Rome, Italy

International Conference on

Leukemia and Hematologic Oncology

Scientific Programconferenceseries.com745th Conference

Page 8

RegistrationsOlimpica 1

Day 1 October 17, 2016

Group PhotoSymposium

Title: Chronic lymphocytic leukemia: Risk factors and complications Olfat M Hendy, Menoufia University, EgyptTitle: The Diagnostic and prognostic value of CD38 and CD49d Expressions in chronic lymphocytic leukemiaOlfat M Hendy, Menoufia University, Egypt

Networking and Refreshment BreakSessions:Leukemia|Hematologic Oncology|ChemotherapySession Chair: Saad Kenderian, Mayo Clinic, USA

Session IntroductionTitle: Fusion molecules as a new concept to take chemotherapy to the next levelThomas Mehrling, Mundipharma EDO GmbH, SwitzerlandTitle: Chimeric Antigen Receptor T Cells in Cancer Immunotherapy beyond CD 19Saad Kenderian, Mayo Clinic, USATitle: Teaching an old dog new tricks: Genetic profiling predicts response in elderly acute myeloid leukemia treated with old/new drugs comboGiuseppe Visani, AORMN Hospital, ItalyTitle: Checkpoint blockade in hematology and stem cell transplantationSaad Kenderian, Mayo Clinic, USA

Lunch BreakSessions:Hematology|Pediatric Oncology|Regenerative medicineSession Chair: Jehan El Sharnoby, Tanta University, Egypt

Session IntroductionTitle: Hemophagocytic lymphohistiocytosis (HLH): A systematic review on approach to diagnosis and management of HLH as an emerging nonmalignant disease with high morbidity and mortality in children and adultsMahdi Shahriari, Shiraz University of Medical Sciences, IranTitle: The value of measurement of circulating tumour cells in hepatocellular carcinomaFatma Khalaf, Menoufia University, EgyptTitle: Evaluation of circulating zonulin as a potential marker in the pathogenesis of non-alcoholic fatty liver disease Mona Aref, Menoufia University, EgyptTitle: Advances in regenerative medicineJehan El Sharnoby, Tanta University, Egypt

Networking and Refreshment BreakTitle: Serum osteopontin and cytokeratin-18 in chronic hepatitis C patientsGamal Y Aboraia, Menoufia University, EgyptTitle:Unusual presentations of acute lymphoblastic leukemia in children: A systematic reviewNader Shakibazad, Shiraz University of Medical Sciences, Iran

Panel Discussion

Opening Ceremonyconferenceseries.com

Keynote ForumIntroductionTitle: Sequential treatment of AML patients with Alvocidib followed by Cytarabine and Mitoxantrone is highly effective through a mechanism dependent on MCL1 expression and functionDavid J Bearss, Tolero Pharmaceuticals, USA

Page 9

Day 2 October 18, 2016Olimpica 1

Special Session 01Title:Diagnosis and treatment of DVT and prevention of DVT recurrence and the PTS: Bridging the gap between DVT and PTS in the primary care setting or outpatient wardJan Jacques Michiels, Goodheart Institute, Netherlands

Networking and Refreshment BreakSpecial Session 02

Title: Inhibition of AXL kinase reverses the mesenchymal phenotype in leukemia cells through the disruption of retinoic acid signalingSteven L. Warner, Tolero Pharmaceuticals, Inc., USA Sessions: Pediatric hematologist/oncologist|Leukemia Risk factors|Hemato Immunology &Stem Cell Research|Leukemia ImmunologySession Chair: Olfat M Hendy, Menoufia University, Egypt

Session IntroductionTitle: Syndromatic osteosarcoma, does it carry a poor prognosis? King Hussein Cancer centre experienceAbdulqader Alhebshi, Prince Mohammed Bin Abdulazizi Hospital, Saudi Arabia

Lunch BreakTitle: Hepcidin levels and iron status in β- thalassemia major patients with hepatitis C virus infectionOlfat M Hendy, Menoufia University, EgyptTitle: Potential late effects in survivors of childhood cancersMahdi Shahriari, Shiraz University of Medical Sciences, IranTitle: DNA-poor space in Hodgkin’s lymphoma nucleiSabine Mai, University of Manitoba, CanadaTitle: The role of bone marrow cells in therapy of childhood acute lymphoblastic leukemia that create an abnormal specific hematopoietic microenvironmentAhmad Reza Rahnemoon, Iran University of Medical Sciences, Iran

Panel DiscussionYoung Researcher Forum

YRF Judge: Steven L Warner, Tolero Pharmaceuticals, Inc., USA Session Introduction

Title: Detection of circulating lamin b1& glypican-3 for early diagnosis of hepatocellular carcinoma patientsWaleed Fathy, Menoufia University, EgyptTitle: Study of miRNA-146a as a downregulator of CXCR4 expression in acute myeloid leukemiasNouran Nabil Momen, Cairo University, EgyptTitle: Haptoglobin phenotypes as a risk factor for coronary artery disease in type 2 diabetes mellitus: An Egyptian studyFatma Khalaf, Menoufia University, EgyptTitle: The Proton channel hvcn1 inhibits leukaemia progression in the cll mouse model Eμ-TCL1 and regulates sialylation of T antigen in MMAlaa Alyahyawi, Queen Mary University of London, UKTitle: Laboratory characteristics of children with Acute Lymphocytic Leukemia (ALL) carrying different fusion geneAhmad Reza Rahnemoon, Iran University of Medical Sciences, Iran

Networking and Refreshment BreakThanks giving & Closing Ceremony

622nd Conferenceconferenceseries.com

Scientific Program

5th World Hematologists CongressAugust 18-19, 2016 London, UK

Page 11

RegistrationsDay 1 August 18, 2016

Networking & Refreshment BreakMajor Sessions: Hematology | Hematologic OncologySession Chair: John Batchelor, Central Manchester Foundation Trust, UKSession Co-chair: Shaoying Li, University of Texas MD Anderson Cancer Center, USA

Session IntroductionTitle: MYC/BCL2 double hit high grade B-cell lymphomaShaoying Li, University of Texas MD Anderson Cancer Center, USATitle: The management of traumatic intracranial hemorrhage in patients taking pre-injury antiplatelet agents: An updateJohn Batchelor, Central Manchester Foundation Trust, UKTitle: Clinical applications of immunoglobulin expression in acute myeloid leukemiaC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Treating polycythemia vera with Ruxolitinib: An update from the RESPONSE 1 & 2 trialsSimon Durrant, University of Queensland, AustraliaTitle: L-arginine and nitric oxide levels among hypertensive patient in Sokoto, North Western NigeriaErhabor Osaro, Usmanu Danfodiyo University, Nigeria

Group PhotoLunch Break

Major Sessions: Blood Disorders|Diagnosis of Blood DisordersSession Chair: C Cameron Yin, University of Texas MD Anderson Cancer Center, USASession Co-chair: Rashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center, USA

Session IntroductionTitle: Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: From Dameshek 1950 to Vainchenker 2005 and beyondJ J Michiels, Goodheart Institute, NetherlandsTitle: Clinical significance of CD5 expression in B-cell lymphomasC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Repurposed therapies in AML and MDSKen Mills, Queen’s University Belfast, UKTitle: Myeloid neoplasms with isochromosome 17q: A distinct entity with unique clinicopathologic and genetic featuresRashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center, USA

Networking & Refreshment BreakTitle: Thrombotic complications in inherited bleeding disorders: The problem of aging populationPavol Holly, University Hospital Martin, SlovakiaTitle: Updates in markers of childhood leukemiaJackleen Awadallah Raafat, National Research Center, EgyptTitle: Target joint: New concept of identificationMousa Mohammad Thalath Alhaosawi, Almadinah General Hospital, Saudi ArabiaTitle: Resolve of the minors in inherited bloodAyesha Junaid, Shifa International Hospitals Ltd., PakistanVP: Preventing early relapse in breast cancer: Perioperative NSAID may prevent awakening of dormant single cells and avascular micrometastasesMichael Retsky, Harvard TH Chan School of Public Health, USA

Panel Discussion


Keynote ForumKeynote ForumIntroductionTitle: MicroRNAs in stored blood cells: What future do they hold in transfusion medicine?C D Atreya, U S Food and Drug Administration, USATitle: Molecular basis of acute myeloid leukemiaKen Mills, Queen’s University Belfast, UKTitle: 2016 WHO clinical molecular and pathological criteria for classification and staging of myeloproliferative neoplasms (MPN) caused by MPN driver mutations in the JAK2, MPL and CALR genes in the context of newJ J Michiels, Goodheart Institute, Netherlands

Page 12

Day 2 August 19, 2016

Keynote ForumIntroductionTitle: Coagulopathy in traumatic brain injury: Current concepts and controversiesJohn Batchelor, Central Manchester Foundation Trust, UKTitle: Shotha and the Unified Theory of Inflammatory DiseasesRajavashisth Tripathi, Banaras Hindu University, India

Sessions: Treatment of Blood Disorder | Hematology ResearchSession Chair: Rajavashisth Tripathi, Banaras Hindu University, IndiaSession Co-chair: Visweshwar Nathan, University of South Florida, USA

Session IntroductionTitle: MicroRNA-1246 is a potential regulator of factor 8 geneC D Atreya, U S Food and Drug Administration, USA

Networking & Refreshment BreakTitle: Validity of on demand treatment in hemophilia patients based on patient's perception of a joint bleed impact on resources in developing countriesVisweshwar Nathan, University of South Florida, USATitle: Secondary myelofibrosis in the natural history of JAK2, MPL and CALR mutated myeloproliferative neoplasmsJ J Michiels, Goodheart Institute, NetherlandsTitle: Coagulation factor IX regulates cell migration and adhesion in vitroChiaki Hidai, Nihon University, JapanTitle: Proteomic variability and inflammation: Novel biomarkers and pathwaysRajavashisth Tripathi, Banaras Hindu University, IndiaTitle: Glucose 6 phosphate dehydrogenase (G6PD) enzyme deficiency in jaundiced infants in Khyber PakhtunkhwaShahtaj Khan, Hayatabad Medical Complex, Pakistan

Lunch BreakTitle: Interpreting circulating immature plasma cells in plasma cell leukemia using 5 part differential cell counterNishit Kumar Gupta, Nishit Clinical Laboratory Pvt. Ltd., IndiaTitle: Comparative study of serum ferritin level between pre and post menopausal women attending Usmanu Danfodiyo University Teaching Hospital (UDUTU), Sokoto, NigeriaErhabor Osaro, Usmanu Danfodiyo University, NigeriaSessions: Various aspects of Hematology | Case reports and EpidemiologySession Chair: Simon Durrant, University of Queensland, Australia

Session IntroductionTitle: Acquired hemophilia properly diagnosed, successfully treated: A report of 9 casesBozena Sokolowska, Medical University of Lublin, PolandTitle: Survival and clinical aspects for patients with chronic lymphocytic leukemia in Kermanshah, IranMehrdad Payandeh, Kermanshah University of Medical Sciences, Iran

Networking & Refreshment BreakTitle: Advances in stem cell and gene therapy for hemophiliaNaser Mobarra, University of Medical Sciences, IranTitle: Epidemiology of lymphoma associated HTLV1Zahra Mozaheb, Mashhad University of Medical Science, IranTitle: Assessment of some hematological parameters of mortuary workers exposed to embalming chemicals in some mortuaries in Anambra state, NigeriaWinifred Onwurah, Nnamdi Azikiwe University, NigeriaVP: Frequency and management of venous thrombosis in adult acute leukemia patients at a tertiary care hospital of PakistanM Shahzad Sarwar, Aga Khan University Hospital, Pakistan

Poster PresentationPanel DiscussionAward Ceremony

October 03-05, 2016 Orlando, USA

6th International Conference on

Hematology

Scientific Program


Page 14

RegistrationsDay 1 October 03, 2016

Group Photo

Lunch Break

Session 1 : Hematology | Hematologic Oncology

Session Chair: Sihem Bihorel, University of Florida, USA

Session Introduction

Title: Diabetes 1, 2 and 3 (Alzheimer’s disease) cause defects in carbohydrate metabolism and originate from chronic inflammation linked to excessive peroxynitrite metabolism which kills mitochondriaKnox Van Dyke, West Virginia University Medical School, USATitle: Mechanisms of hematological toxicity of antibody drug conjugates: Role of drug-load releaseSihem Bihorel, University of Florida, USA Title: Clinical applications of immunoglobulin expression in acute myeloid leukemiaC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Study of north Indian blood donors: Attitude, obstacles and motivation towards donation (VP)Tenzin Saldon, All India Institute of Medical Sciences, India

Networking and Refreshment Break

Title: How we approach chronic myeloid leukemia in a teaching hospital with limited resources in the tyrosine kinase era: Results of the first hundred patients treated with tyrosine kinase inhibitorsGerman Espino L, Caja del Seguro Social, Panama Title: Molecular monitoring of chronic myelogenous leukemiaC Cameron Yin, University of Texas MD Anderson Cancer Center, USATitle: Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies Chakra P Chaulagain, Cleveland Clinic Florida, USA

Poster Presentation

Panel Discussion


Session 2: Blood Disorders | Diagnosis and Treatment

Session Chair: Johns Stephen Batchelor, Central Manchester Foundation Trust, UK

Session Introduction


Keynote ForumIntroduction

Title: The incredible costs of chronic diseases: Why they occur and possible preventions and/or treatmentsKnox Van dyke, West Virginia University Medical School, USA

Networking and Refreshment BreakTitle: Coagulopathy in traumatic brain injury: Current concepts and controversiesJohns Stephen Batchelor, Central Manchester Foundation Trust, UKTitle: Clinical application of molecular testing in myeloid leukemiaC Cameron Yin, University of Texas MD Anderson Cancer Center, USA

Page 15

Title: The pathogenesis of spontaneous intracranial hemorrhage in patients with hematological malignancyJohns Stephen Batchelor, Central Manchester Foundation Trust, UKTitle: The quality of blood sample collection for preclinical testing: A focus on rat tail bleeding method Nidal A Qinna, University of Petra, Jordan


Title: Intracranial hemorrhage-with oral anti-coagulant therapyVisweshwar Nathan, University of South Florida, USATitle: New Treatments for Diabetes Aimed at the Actual Disease State Itself Knox Van Dyke, West Virginia University Medical School, USA

Young Researcher Forum

Title: What matters for people with sickle cell disease and their families?Khulud Abudawood, University of Florida College of Nursing, USATitle: Functional characterization of T-cell subsets in acquired aplastic anemia patients: Pilot studyVandana Sharma, All India Institute of Medical Sciences, India

Lunch BreaK

Title: Assessment of Chemotherapeutic Responsiveness in Non-Hodgkin Lymphoma Patients at KAH, Al Ahsa KSAAreeg bala elbashir Mohamed ahmed,King Abdulaziz Hospital-Al Ahsa, Saudi ArabiaTitle: Updates on systemic AL amyloidosis Chakra P Chaulagain, Cleveland Clinic Florida, USA

Special Session on

Title: The effect of time and temperature variables on some routine coagulation tests among subjects of African descent in Sokoto, North Western NigeriaErhabor Osaro, Usmanu Danfodiyo University, Nigeria


Video Presentation

Title: Updates in markers of childhood leukaemiaJackleen Raafat Awadallah, National Research Center, EgyptTitle: Silicosis and Black Lung Diseases –Classical Model of Chronic DiseasesKnox Van Dyke, West Virginia University Medical School, USA



Lunch Break

Thanks Giving & Closing Ceremony

Conference Series Ltd2360 Corporate Circle, Suite 400 Henderson, NV 89074:7722, USA

Ph: +1:888:843:8169, Fax: +1:650:618:1417, Toll free: +1:800:216:6499http://leukemia.conferenceseries.com/; Email:[email protected]; [email protected]

Hematology & Blood DisordersNovember 02-04, 2015 Atlanta, USA

3rd International Conference on

Scientific Program

Media Partners

Collaborator

Page 17

Registrations

Day 1 November 02, 2015

Group PhotoNetworking & Refreshments Break

Track 1: Hematologic MalignanciesSession Chair: Ken Mills, Queen’s University Belfast, UKSession Co-Chair: Ulla Randen, Oslo University Hospital, Norway

Session IntroductionTitle: The current landscape of myelodysplastic syndromes Michael Keng, University of Virginia, USATitle: Identifying novel epigenetically induced synthetic lethality therapeutic combinations for high risk MDS/AMLKen Mills, Queen’s University Belfast, UKTitle: Effect of intestinal microbiota on lymphoma and longevity in Atm deficient miceRobert H Schiestl, University of California, USATitle: Primary cold agglutinin disease (CAD) associated lymphoproliferative disease: A new entityUlla Randen, Oslo University Hospital, NorwayTitle: The therapeutic potential of the translation initiation factor eIF2α serine 51 phosphorylation for chronic myeloid leukemiaKatarzyna Piwocka, Nencki Institute of Experimental Biology, Poland

Lunch BreakTitle: Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reactionAbdel Rahim Mahmoud Muddathir, Taibah University, KSATilte: CD5-positive B-cell lymphomasC Cameron Yin, University of Texas, USA

Special Session on Acquired thrombotic thrombocytopenic purpura: Disease pathogenesis, laboratory monitoring and current treatment strategies by

Jay S Raval, University of North Carolina, USATrack 2: Blood- Components and FunctionsTrack 3: Hemato-immunology & Stem Cell ResearchSession Chair: Dianzheng Zhang, Philadelphia College of Osteopathic Medicine, USASession Co-Chair: Jay S Raval, University of North Carolina, USATitle: MicroRNA as biomarker for acute graft versus host diseaseDianzheng Zhang, Philadelphia College of Osteopathic Medicine, USATitle: Role of antioxidants and polyphenols in thrombosis and haemostatic functionAbishek B Santhakumar, Central Queensland University, AustraliaTitle: Dendritic cell-based cancer immunotherapyShigetaka Shimodaira, Shinshu University Hospital, Japan

Networking & Refreshments Break

Opening CeremonyKeynote Forum

IntroductionRobert H SchiestlUniversity of California, USA

C Cameron YinUniversity of Texas, USA

Hematology & Blood DisordersNovember 02-04, 2015 Atlanta, USA

3rd International Conference on Scientific Program


Page 18

Title: Effect of group of genetic markers on induction of fetal hemoglobin and disease severity in hemoglobinopathiesAnita Nadkarni, National Institute of Immunohematology, IndiaTitle: Cytogenetic biomarkers as indicators of the absorbed dose in the peripheral leukocytes of head & neck cancer patients undergoing radiotherapyShyama Soorambail Keshava, Goa University, IndiaTitle: Single donor versus pooled random donor platelet concentrates: A review of literatureSayeedul Hasan Arif, Jawaharlal Nehru Medical College, India

Panel Discussion


Knox Van DykeWest Virginia University, USARobert Michael DavidsonThe American Institute of Stress, USA

Keynote Forum

Networking & Refreshments BreakTrack 4: Diagnosis, Treatment and Management of Blood DisordersSession Chair: Rania A Zayed, Cairo University, Egypt

Session IntroductionTitle: Risk factors for intracranial haemorrhage in elderly patients with blunt head traumaJohn S Batchelor, Central Manchester Foundation Trust, UKTitle: Characterization of RBC mechanical properties by microfluidic techniquesAnnie Viallat, University Aix-Marseille, FranceTitle: Indoleamine 2,3 dioxygenase and regulatory T cells in acute myeloid leukemiaRania A Zayed, Cairo University, EgyptTitle: Kozhikode Criteria’ for diagnosing SLE as a Haematological Disorder P K Sasidharan, University of Calicut, IndiaTitle: Blood transfusion reaction in pediatric age group: A tertiary care centre based studySuhailur Rehman, Aligarh Muslim University, India

Lunch BreakSpecial Session on New Drug Development in Hematology by

Knox Van Dyke, West Virgina University, USA & Erhabor Osaro, Usmanu Danfodiyo University, Nigeria

Networking & Refreshments BreakYoung Researchers Forum

Title: Adult T-cell leukemia/lymphoma (ATLL): Where we are in 2015Nikhil Mukhi, SUNY Downstate Medical Center, USATitle: Post-ERCP pancreatitis: A rare cause of atypical hemolytic uremic syndromeSuresh Manapuram, Allegheny General Hospital, USATitle: The role of different aggregating agents in the inhibition of nitric oxide synthesis in platelet aggregationDebipriya Banerjee, Sinha Institute of Medical Science & Technology, IndiaTitle: Correlative study of Mentzer’s index, RDWI and Hb electrophoresis for β-thalassemia traitSuhailur Rehman, Aligarh Muslim University, IndiaTitle: Hemophilia- Evolution and challenges in MadagascarOlivia Ndjib, Antananarivo University, Madagascar

Poster PresentationPanel Discussion


Symposium on Tropical Blood Disorders byErhabor Osaro, Usmanu Danfodio University, Nigeria

Session Chair: Erhabor Osaro, Usmanu Danfodiyo University, Nigeria Session Introduction

Title: Effect of Plasmodium parasitaemia on some haematological parameters in children living in sokoto, North Western, NigeriaErhabor Osaro, Usmanu Danfodiyo University, NigeriaTitle: Gene expression of P-selectin in malaria infectionOkorie Hope Mery, Imo State University, Nigeria

Title: Effect of malaria infection on packed cell volume and haemoglobin levels among patients at OJO district of lagos state NigeriaIwunze Vincent Okechukwu, Life-link Medical Diagnostic & Labs. Ltd , Nigeria

Networking & Refreshments BreakTitle: Disharmony and lack of teamwork among health professionals; an emerging challenge in the management of blood disorders in NigeriaEmmanuel Kufre Uko, University of Calabar, NigeriaTitle: Screening for HBsAg and HCV antibodies among military personnel in the Niger Delta of NigeriaAzuonwu Obioma, University of Science and Technology Port, Nigeria Title: Changes in some haemostatic parameters in pregnancy and peurperium in Port HarcourtEchonwere Beauty, Rivers State University of Science and Technology , NigeriaTitle: Malaria parasitaemia among long distance truck drivers in the Niger delta of NigeriaFredrick Christy C, University of Abuja, Nigeria

Special Session on Biophysical aspects of the Sanarelli-Shwartzman phenomenon byRobert Michael Davidson, The American Institute of Stress, USA

Lunch BreakTrack 5: Various Aspects of HematologySession Chair: Harald Engan, Mid Sweden University, Sweden

Session IntroductionTitle: Hemoconcentration following spleen contractionHarald Engan, Mid Sweden University, SwedenTitle: Epidemiological aspects of intrafamilial spread of HCV iInfection in Egyptianp Population: A pilot studyDalia Omran, Cairo University, EgyptTilte: Extramedullary plasmablastic plasma cell myeloma presenting as plasmablastic lymphomaAmar Ranjan, All India Institute of Medical Sciences, IndiaTitle: The effect of hematology in African hospitals and patientsUdodirim Evelyn Okoro, Federal Medical Center Umuahia, NigeriaTitle: Serum prohepcidin and iron metabolism in chloramphenicol induced anaemia in ratsChristopher Chijindu Osubor, University of Benin, NigeriaTitle: Challenges associated with the effective management of major haemorrhage in developing countriesErhabor Osaro, Usmanu Danfodiyo University, Nigeria

Networking & Refreshments BreakClosing Ceremony

Documents

th Leukemia and Hematologic Oncology · conferenceseries.com Hematologic Oncology 2017 Conference Secretariat Conference Series LLC 2360 Corporate Circle, Suite 400 Henderson,